[1] Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA. Placenta accreta[J]. Am J Obstet Gynecol, 2010,203(5):430-439.
[2] Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisiplinary care team compared with standard obstetric care[J]. Obstet Gynaecol,2011,117(2 Pt 1):331-337.
[3] 陈敦金. 胎盘植入[M]. 长沙:湖南科学技术出版社,2013:3-17.
[4] 谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:212-214.
[5] Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta[J]. Obstet Gynecol, 2012,120(1):207-211.
[6] Tam KB, Dozier J, Martin JN Jr. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review[J]. J Matern Fetal Neonatal Med, 2012,25(4):329-334.
[7] Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta[J]. Obstet Gynecol Int, 2012,2012:873929.
[8] Wright JD, Herzog TJ, Shah M, et al. Regionalization of care for obstetric hemorrhage and its effect on maternal mortality[J]. Obstet Gynecol 2010,115(6):1194-1200.
[9] Rath W, Hackethal A, Bohlmann MK. Second-line treatment of postpartum haemorrhage (PPH) [J]. Arch Gynecol Obstet,2012,286(3):549-561.
[10] Shamsa A, Harris A, Anpalagan A. Peripartum hysterectomy in a tertiary hospital in Western Sydney[J]. J Obstet Gynaecol,2014,29: 1-4.
[11] Bauer ST, Bonanno C. Abnormal placentation[J]. Semin Perinatol 2009,33(2):88-96.
[12] Eller AG, Porter TF, Soisson P,et al. Optimal management strategies for placenta accreta[J]. BJOG,2009,116(5):648-654.
[13] Rosen T. Placenta accreta and cesarean scar pregnancy: overlooked costs of the rising cesarean section rate[J]. Clin Perinatol,2008,35(3):519-529,x.
[14] Al-Khan A, Gupta V, Illsley NP, et al.Maternal and fetal outcomes in placenta accreta after institution of team-managed care[J].Reprod Sci, 2014,21(6):761-771.
(2014-12-01 收稿 2015-02-08 修回) |